organization · Reporting owner

Insight Venture Partners (Cayman) X, L.P.

Disclosed activity across 3 companies

Tapewire entity: 31213
SEC CIK: 0001710860

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

No relationships currently tracked through insider filings.

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

No balances currently tracked through insider filings.

Past disclosures · reporting ended (3)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Hinge Health, Inc.

Report date July 07, 2026 · Filed July 10, 2026

Jointly reported with Insight Holdings Group, LLC, Insight Venture Associates X, L.P., Insight Venture Associates X, Ltd., Insight Venture Partners (Delaware) X, L.P., Insight Venture Partners X (Co-Investors), L.P., Insight Venture Partners X, L.P.

Section 16 reporting ended · disclosed 2026-07-10. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	IndirectSee footnotes	122,188	Reported balance After 2026-07-07 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2026-07-07 · Conversion · Acquired 122,188 · Balance 122,188 F8: See Exhibit 99.1 F1: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1
Class A Common StockSEC Table I · non-derivative	IndirectSee footnotes	2,907	Reported balance After 2026-07-07 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 2 · 2026-07-07 · Conversion · Acquired 2,907 · Balance 2,907 F8: See Exhibit 99.1 F2: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1
Class A Common StockSEC Table I · non-derivative	IndirectSee footnotes	100,195	Reported balance After 2026-07-07 transaction · row 3 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 3 · 2026-07-07 · Conversion · Acquired 100,195 · Balance 100,195 F8: See Exhibit 99.1 F3: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1
Class A Common StockSEC Table I · non-derivative	IndirectSee footnotes	19,382	Reported balance After 2026-07-07 transaction · row 4 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 4 · 2026-07-07 · Conversion · Acquired 19,382 · Balance 19,382 F8: See Exhibit 99.1 F4: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1
Class A Common StockSEC Table I · non-derivative	IndirectSee footnotes	0	Reported balance After 2026-07-07 transaction · row 5 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 5 · 2026-07-07 · Sale · Disposed 122,188 · Balance 0 F12: See Exhibit 99.1 F9: See Exhibit 99.1 F1: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1
Class A Common StockSEC Table I · non-derivative	IndirectSee footnotes	0	Reported balance After 2026-07-07 transaction · row 6 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 6 · 2026-07-07 · Sale · Disposed 2,907 · Balance 0 F12: See Exhibit 99.1 F9: See Exhibit 99.1 F2: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1
Class A Common StockSEC Table I · non-derivative	IndirectSee footnotes	0	Reported balance After 2026-07-07 transaction · row 7 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 7 · 2026-07-07 · Sale · Disposed 100,195 · Balance 0 F12: See Exhibit 99.1 F9: See Exhibit 99.1 F3: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1
Class A Common StockSEC Table I · non-derivative	IndirectSee footnotes	0	Reported balance After 2026-07-07 transaction · row 8 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 8 · 2026-07-07 · Sale · Disposed 19,382 · Balance 0 F12: See Exhibit 99.1 F9: See Exhibit 99.1 F4: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1
Class A Common StockSEC Table I · non-derivative	IndirectSee footnotes	90,640	Reported balance After 2026-07-09 transaction · row 9 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 9 · 2026-07-09 · Conversion · Acquired 90,640 · Balance 90,640 F8: See Exhibit 99.1 F1: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1
Class A Common StockSEC Table I · non-derivative	IndirectSee footnotes	2,156	Reported balance After 2026-07-09 transaction · row 10 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 10 · 2026-07-09 · Conversion · Acquired 2,156 · Balance 2,156 F8: See Exhibit 99.1 F2: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1
Class A Common StockSEC Table I · non-derivative	IndirectSee footnotes	74,325	Reported balance After 2026-07-09 transaction · row 11 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 11 · 2026-07-09 · Conversion · Acquired 74,325 · Balance 74,325 F8: See Exhibit 99.1 F3: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1
Class A Common StockSEC Table I · non-derivative	IndirectSee footnotes	14,378	Reported balance After 2026-07-09 transaction · row 12 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 12 · 2026-07-09 · Conversion · Acquired 14,378 · Balance 14,378 F8: See Exhibit 99.1 F4: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1
Class A Common StockSEC Table I · non-derivative	IndirectSee footnotes	2,792	Reported balance After 2026-07-09 transaction · row 13 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 13 · 2026-07-09 · Sale · Disposed 87,848 · Balance 2,792 F12: See Exhibit 99.1 F10: See Exhibit 99.1 F1: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1
Class A Common StockSEC Table I · non-derivative	IndirectSee footnotes	66	Reported balance After 2026-07-09 transaction · row 14 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 14 · 2026-07-09 · Sale · Disposed 2,090 · Balance 66 F12: See Exhibit 99.1 F10: See Exhibit 99.1 F2: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1
Class A Common StockSEC Table I · non-derivative	IndirectSee footnotes	2,289	Reported balance After 2026-07-09 transaction · row 15 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 15 · 2026-07-09 · Sale · Disposed 72,036 · Balance 2,289 F12: See Exhibit 99.1 F10: See Exhibit 99.1 F3: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1
Class A Common StockSEC Table I · non-derivative	IndirectSee footnotes	443	Reported balance After 2026-07-09 transaction · row 16 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 16 · 2026-07-09 · Sale · Disposed 13,935 · Balance 443 F12: See Exhibit 99.1 F10: See Exhibit 99.1 F4: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1
Class A Common StockSEC Table I · non-derivative	IndirectSee footnotes	0	Reported balance After 2026-07-09 transaction · row 17 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 17 · 2026-07-09 · Sale · Disposed 2,792 · Balance 0 F12: See Exhibit 99.1 F11: See Exhibit 99.1 F1: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1
Class A Common StockSEC Table I · non-derivative	IndirectSee footnotes	0	Reported balance After 2026-07-09 transaction · row 18 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 18 · 2026-07-09 · Sale · Disposed 66 · Balance 0 F12: See Exhibit 99.1 F11: See Exhibit 99.1 F2: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1
Class A Common StockSEC Table I · non-derivative	IndirectSee footnotes	0	Reported balance After 2026-07-09 transaction · row 19 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 19 · 2026-07-09 · Sale · Disposed 2,289 · Balance 0 F12: See Exhibit 99.1 F11: See Exhibit 99.1 F3: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1
Class A Common StockSEC Table I · non-derivative	IndirectSee footnotes	0	Reported balance After 2026-07-09 transaction · row 20 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 20 · 2026-07-09 · Sale · Disposed 443 · Balance 0 F12: See Exhibit 99.1 F11: See Exhibit 99.1 F4: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1
Class B Common StockSEC Table II · derivative / convertible security	IndirectSee footnotes	3,094,820	Reported balance After 2026-07-07 transaction · row 21 Instrument identity requires review; Table II rows are not merged. 1 source row Row 21 · 2026-07-07 · Conversion · Disposed 122,188 · Balance 3,094,820 F8: See Exhibit 99.1 F5: See Exhibit 99.1 F1: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1
Class B Common StockSEC Table II · derivative / convertible security	IndirectSee footnotes	73,638	Reported balance After 2026-07-07 transaction · row 22 Instrument identity requires review; Table II rows are not merged. 1 source row Row 22 · 2026-07-07 · Conversion · Disposed 2,907 · Balance 73,638 F8: See Exhibit 99.1 F5: See Exhibit 99.1 F2: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1
Class B Common StockSEC Table II · derivative / convertible security	IndirectSee footnotes	2,537,790	Reported balance After 2026-07-07 transaction · row 23 Instrument identity requires review; Table II rows are not merged. 1 source row Row 23 · 2026-07-07 · Conversion · Disposed 100,195 · Balance 2,537,790 F8: See Exhibit 99.1 F5: See Exhibit 99.1 F3: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1
Class B Common StockSEC Table II · derivative / convertible security	IndirectSee footnotes	490,910	Reported balance After 2026-07-07 transaction · row 24 Instrument identity requires review; Table II rows are not merged. 1 source row Row 24 · 2026-07-07 · Conversion · Disposed 19,382 · Balance 490,910 F8: See Exhibit 99.1 F5: See Exhibit 99.1 F4: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1
Class B Common StockSEC Table II · derivative / convertible security	IndirectSee footnotes	3,004,180	Reported balance After 2026-07-09 transaction · row 25 Instrument identity requires review; Table II rows are not merged. 1 source row Row 25 · 2026-07-09 · Conversion · Disposed 90,640 · Balance 3,004,180 F8: See Exhibit 99.1 F5: See Exhibit 99.1 F1: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1
Class B Common StockSEC Table II · derivative / convertible security	IndirectSee footnotes	71,482	Reported balance After 2026-07-09 transaction · row 26 Instrument identity requires review; Table II rows are not merged. 1 source row Row 26 · 2026-07-09 · Conversion · Disposed 2,156 · Balance 71,482 F8: See Exhibit 99.1 F5: See Exhibit 99.1 F2: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1
Class B Common StockSEC Table II · derivative / convertible security	IndirectSee footnotes	2,463,465	Reported balance After 2026-07-09 transaction · row 27 Instrument identity requires review; Table II rows are not merged. 1 source row Row 27 · 2026-07-09 · Conversion · Disposed 74,325 · Balance 2,463,465 F8: See Exhibit 99.1 F5: See Exhibit 99.1 F3: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1
Class B Common StockSEC Table II · derivative / convertible security	IndirectSee footnotes	476,532	Reported balance After 2026-07-09 transaction · row 28 Instrument identity requires review; Table II rows are not merged. 1 source row Row 28 · 2026-07-09 · Conversion · Disposed 14,378 · Balance 476,532 F8: See Exhibit 99.1 F5: See Exhibit 99.1 F4: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1

Filing footnotes · ownership attribution and instrument terms

F1: See Exhibit 99.1

F2: See Exhibit 99.1

F3: See Exhibit 99.1

F4: See Exhibit 99.1

F5: See Exhibit 99.1

F6: See Exhibit 99.1

F7: See Exhibit 99.1

F8: See Exhibit 99.1

F9: See Exhibit 99.1

F10: See Exhibit 99.1

F11: See Exhibit 99.1

F12: See Exhibit 99.1

SentinelOne, Inc.

Report date April 01, 2024 · Filed April 04, 2024

Section 16 reporting ended · disclosed 2024-04-04. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	IndirectSee footnote	3,933,556	Reported balance After 2024-04-01 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2024-04-01 · Conversion · Acquired 3,933,556 · Balance 3,933,556 F1: See Exhibit 99.1 F2: See Exhibit 99.1
Class A Common StockSEC Table I · non-derivative	IndirectSee footnote	3,225,563	Reported balance After 2024-04-01 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 2 · 2024-04-01 · Conversion · Acquired 3,225,563 · Balance 3,225,563 F1: See Exhibit 99.1 F3: See Exhibit 99.1
Class A Common StockSEC Table I · non-derivative	IndirectSee footnote	623,954	Reported balance After 2024-04-01 transaction · row 3 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 3 · 2024-04-01 · Conversion · Acquired 623,954 · Balance 623,954 F1: See Exhibit 99.1 F4: See Exhibit 99.1
Class A Common StockSEC Table I · non-derivative	IndirectSee footnote	93,593	Reported balance After 2024-04-01 transaction · row 4 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 4 · 2024-04-01 · Conversion · Acquired 93,593 · Balance 93,593 F1: See Exhibit 99.1 F5: See Exhibit 99.1
Class A Common StockSEC Table I · non-derivative	IndirectSee footnote	3,887,664	Reported balance After 2024-04-01 transaction · row 5 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 5 · 2024-04-01 · Sale · Disposed 45,892 · Balance 3,887,664 F6: See Exhibit 99.1 F2: See Exhibit 99.1
Class A Common StockSEC Table I · non-derivative	IndirectSee footnote	3,187,931	Reported balance After 2024-04-01 transaction · row 6 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 6 · 2024-04-01 · Sale · Disposed 37,632 · Balance 3,187,931 F6: See Exhibit 99.1 F3: See Exhibit 99.1
Class A Common StockSEC Table I · non-derivative	IndirectSee footnote	616,675	Reported balance After 2024-04-01 transaction · row 7 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 7 · 2024-04-01 · Sale · Disposed 7,279 · Balance 616,675 F6: See Exhibit 99.1 F4: See Exhibit 99.1
Class A Common StockSEC Table I · non-derivative	IndirectSee footnote	92,501	Reported balance After 2024-04-01 transaction · row 8 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 8 · 2024-04-01 · Sale · Disposed 1,092 · Balance 92,501 F6: See Exhibit 99.1 F5: See Exhibit 99.1
Class B Common StockSEC Table II · derivative / convertible security	IndirectSee footnote	8,621,691	Reported balance After 2024-04-01 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2024-04-01 · Conversion · Disposed 3,933,556 · Balance 8,621,691 F1: See Exhibit 99.1 F2: See Exhibit 99.1
Class B Common StockSEC Table II · derivative / convertible security	IndirectSee footnote	7,069,890	Reported balance After 2024-04-01 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2024-04-01 · Conversion · Disposed 3,225,563 · Balance 7,069,890 F1: See Exhibit 99.1 F3: See Exhibit 99.1
Class B Common StockSEC Table II · derivative / convertible security	IndirectSee footnote	1,367,601	Reported balance After 2024-04-01 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2024-04-01 · Conversion · Disposed 623,954 · Balance 1,367,601 F1: See Exhibit 99.1 F4: See Exhibit 99.1
Class B Common StockSEC Table II · derivative / convertible security	IndirectSee footnote	205,141	Reported balance After 2024-04-01 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2024-04-01 · Conversion · Disposed 93,593 · Balance 205,141 F1: See Exhibit 99.1 F5: See Exhibit 99.1

Filing footnotes · ownership attribution and instrument terms

F1: See Exhibit 99.1

F2: See Exhibit 99.1

F3: See Exhibit 99.1

F4: See Exhibit 99.1

F5: See Exhibit 99.1

F6: See Exhibit 99.1

nCino, Inc.

Report date December 09, 2024 · Filed December 11, 2024

Jointly reported with Insight Holdings Group, LLC, Insight SN Holdings 2, LLC, Insight SN Holdings, LLC, Insight Venture Associates X, L.P., Insight Venture Associates X, Ltd., Insight Venture Partners (Delaware) X, L.P., Insight Venture Partners X, L.P., Insight Venture Partners X (Co-Investors), L.P.

Section 16 reporting ended · disclosed 2024-12-11. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee footnote	340,399	Reported balance After 2024-12-09 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2024-12-09 · Sale · Disposed 21,892 · Balance 340,399 F1: See Exhibit 99.1 F3: See Exhibit 99.1
Common StockSEC Table I · non-derivative	IndirectSee footnote	999,315	Reported balance After 2024-12-09 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 2 · 2024-12-09 · Sale · Disposed 37,277 · Balance 999,315 F1: See Exhibit 99.1 F4: See Exhibit 99.1
Common StockSEC Table I · non-derivative	IndirectSee footnote	193,308	Reported balance After 2024-12-09 transaction · row 3 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 3 · 2024-12-09 · Sale · Disposed 7,211 · Balance 193,308 F1: See Exhibit 99.1 F5: See Exhibit 99.1
Common StockSEC Table I · non-derivative	IndirectSee footnote	907,255	Reported balance After 2024-12-09 transaction · row 4 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 4 · 2024-12-09 · Sale · Disposed 24,649 · Balance 907,255 F1: See Exhibit 99.1 F6: See Exhibit 99.1
Common StockSEC Table I · non-derivative	IndirectSee footnote	286,590	Reported balance After 2024-12-10 transaction · row 5 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 5 · 2024-12-10 · Sale · Disposed 53,809 · Balance 286,590 F2: See Exhibit 99.1 F3: See Exhibit 99.1
Common StockSEC Table I · non-derivative	IndirectSee footnote	907,693	Reported balance After 2024-12-10 transaction · row 6 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 6 · 2024-12-10 · Sale · Disposed 91,622 · Balance 907,693 F2: See Exhibit 99.1 F4: See Exhibit 99.1
Common StockSEC Table I · non-derivative	IndirectSee footnote	175,585	Reported balance After 2024-12-10 transaction · row 7 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 7 · 2024-12-10 · Sale · Disposed 17,723 · Balance 175,585 F2: See Exhibit 99.1 F5: See Exhibit 99.1
Common StockSEC Table I · non-derivative	IndirectSee footnote	846,672	Reported balance After 2024-12-10 transaction · row 8 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 8 · 2024-12-10 · Sale · Disposed 60,583 · Balance 846,672 F2: See Exhibit 99.1 F6: See Exhibit 99.1

Filing footnotes · ownership attribution and instrument terms

F1: See Exhibit 99.1

F2: See Exhibit 99.1

F3: See Exhibit 99.1

F4: See Exhibit 99.1

F5: See Exhibit 99.1

F6: See Exhibit 99.1

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
July 09, 2026 Filed Jul 10, 2026 01:17 UTC	Hinge Health, Inc. HNGE · Entity 377	ConversionClass B Common Stock · Derivative	14,378	Not disclosed	Not disclosed	Disclosure SEC source: 0000899140-26-000710 · form4.xml · derivative · entry 28 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 476,532 Underlying: Class A Common Stock · 14,378 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
July 09, 2026 Filed Jul 10, 2026 01:17 UTC	Hinge Health, Inc. HNGE · Entity 377	ConversionClass B Common Stock · Derivative	74,325	Not disclosed	Not disclosed	Disclosure SEC source: 0000899140-26-000710 · form4.xml · derivative · entry 27 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 2,463,465 Underlying: Class A Common Stock · 74,325 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
July 09, 2026 Filed Jul 10, 2026 01:17 UTC	Hinge Health, Inc. HNGE · Entity 377	ConversionClass B Common Stock · Derivative	2,156	Not disclosed	Not disclosed	Disclosure SEC source: 0000899140-26-000710 · form4.xml · derivative · entry 26 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 71,482 Underlying: Class A Common Stock · 2,156 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
July 09, 2026 Filed Jul 10, 2026 01:17 UTC	Hinge Health, Inc. HNGE · Entity 377	ConversionClass B Common Stock · Derivative	90,640	Not disclosed	Not disclosed	Disclosure SEC source: 0000899140-26-000710 · form4.xml · derivative · entry 25 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 3,004,180 Underlying: Class A Common Stock · 90,640 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
July 09, 2026 Filed Jul 10, 2026 01:17 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	443	$91.00	$40,313.00	Disclosure SEC source: 0000899140-26-000710 · form4.xml · nonDerivative · entry 20 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 0 F12 · kind: See Exhibit 99.1 F11 · price: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
July 09, 2026 Filed Jul 10, 2026 01:17 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	2,289	$91.00	$208,299.00	Disclosure SEC source: 0000899140-26-000710 · form4.xml · nonDerivative · entry 19 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 0 F12 · kind: See Exhibit 99.1 F11 · price: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
July 09, 2026 Filed Jul 10, 2026 01:17 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	66	$91.00	$6,006.00	Disclosure SEC source: 0000899140-26-000710 · form4.xml · nonDerivative · entry 18 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 0 F12 · kind: See Exhibit 99.1 F11 · price: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
July 09, 2026 Filed Jul 10, 2026 01:17 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	2,792	$91.00	$254,072.00	Disclosure SEC source: 0000899140-26-000710 · form4.xml · nonDerivative · entry 17 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 0 F12 · kind: See Exhibit 99.1 F11 · price: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
July 09, 2026 Filed Jul 10, 2026 01:17 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	13,935	$90.17	$1,256,574.69	Disclosure SEC source: 0000899140-26-000710 · form4.xml · nonDerivative · entry 16 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 443 F12 · kind: See Exhibit 99.1 F10 · price: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
July 09, 2026 Filed Jul 10, 2026 01:17 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	72,036	$90.17	$6,495,774.26	Disclosure SEC source: 0000899140-26-000710 · form4.xml · nonDerivative · entry 15 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 2,289 F12 · kind: See Exhibit 99.1 F10 · price: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
July 09, 2026 Filed Jul 10, 2026 01:17 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	2,090	$90.17	$188,463.66	Disclosure SEC source: 0000899140-26-000710 · form4.xml · nonDerivative · entry 14 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 66 F12 · kind: See Exhibit 99.1 F10 · price: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
July 09, 2026 Filed Jul 10, 2026 01:17 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	87,848	$90.17	$7,921,605.55	Disclosure SEC source: 0000899140-26-000710 · form4.xml · nonDerivative · entry 13 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 2,792 F12 · kind: See Exhibit 99.1 F10 · price: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
July 09, 2026 Filed Jul 10, 2026 01:17 UTC	Hinge Health, Inc. HNGE · Entity 377	ConversionClass A Common Stock	14,378	Not disclosed	Not disclosed	Disclosure SEC source: 0000899140-26-000710 · form4.xml · nonDerivative · entry 12 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 14,378 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
July 09, 2026 Filed Jul 10, 2026 01:17 UTC	Hinge Health, Inc. HNGE · Entity 377	ConversionClass A Common Stock	74,325	Not disclosed	Not disclosed	Disclosure SEC source: 0000899140-26-000710 · form4.xml · nonDerivative · entry 11 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 74,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
July 09, 2026 Filed Jul 10, 2026 01:17 UTC	Hinge Health, Inc. HNGE · Entity 377	ConversionClass A Common Stock	2,156	Not disclosed	Not disclosed	Disclosure SEC source: 0000899140-26-000710 · form4.xml · nonDerivative · entry 10 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 2,156 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
July 09, 2026 Filed Jul 10, 2026 01:17 UTC	Hinge Health, Inc. HNGE · Entity 377	ConversionClass A Common Stock	90,640	Not disclosed	Not disclosed	Disclosure SEC source: 0000899140-26-000710 · form4.xml · nonDerivative · entry 9 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 90,640 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
July 07, 2026 Filed Jul 10, 2026 01:17 UTC	Hinge Health, Inc. HNGE · Entity 377	ConversionClass B Common Stock · Derivative	19,382	Not disclosed	Not disclosed	Disclosure SEC source: 0000899140-26-000710 · form4.xml · derivative · entry 24 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 490,910 Underlying: Class A Common Stock · 19,382 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
July 07, 2026 Filed Jul 10, 2026 01:17 UTC	Hinge Health, Inc. HNGE · Entity 377	ConversionClass B Common Stock · Derivative	100,195	Not disclosed	Not disclosed	Disclosure SEC source: 0000899140-26-000710 · form4.xml · derivative · entry 23 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 2,537,790 Underlying: Class A Common Stock · 100,195 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
July 07, 2026 Filed Jul 10, 2026 01:17 UTC	Hinge Health, Inc. HNGE · Entity 377	ConversionClass B Common Stock · Derivative	2,907	Not disclosed	Not disclosed	Disclosure SEC source: 0000899140-26-000710 · form4.xml · derivative · entry 22 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 73,638 Underlying: Class A Common Stock · 2,907 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
July 07, 2026 Filed Jul 10, 2026 01:17 UTC	Hinge Health, Inc. HNGE · Entity 377	ConversionClass B Common Stock · Derivative	122,188	Not disclosed	Not disclosed	Disclosure SEC source: 0000899140-26-000710 · form4.xml · derivative · entry 21 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 3,094,820 Underlying: Class A Common Stock · 122,188 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
July 07, 2026 Filed Jul 10, 2026 01:17 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	19,382	$90.23	$1,748,766.15	Disclosure SEC source: 0000899140-26-000710 · form4.xml · nonDerivative · entry 8 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 0 F12 · kind: See Exhibit 99.1 F9 · price: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
July 07, 2026 Filed Jul 10, 2026 01:17 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	100,195	$90.23	$9,040,224.13	Disclosure SEC source: 0000899140-26-000710 · form4.xml · nonDerivative · entry 7 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 0 F12 · kind: See Exhibit 99.1 F9 · price: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
July 07, 2026 Filed Jul 10, 2026 01:17 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	2,907	$90.23	$262,287.85	Disclosure SEC source: 0000899140-26-000710 · form4.xml · nonDerivative · entry 6 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 0 F12 · kind: See Exhibit 99.1 F9 · price: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
July 07, 2026 Filed Jul 10, 2026 01:17 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	122,188	$90.23	$11,024,571.14	Disclosure SEC source: 0000899140-26-000710 · form4.xml · nonDerivative · entry 5 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 0 F12 · kind: See Exhibit 99.1 F9 · price: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
July 07, 2026 Filed Jul 10, 2026 01:17 UTC	Hinge Health, Inc. HNGE · Entity 377	ConversionClass A Common Stock	19,382	Not disclosed	Not disclosed	Disclosure SEC source: 0000899140-26-000710 · form4.xml · nonDerivative · entry 4 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 19,382 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
July 07, 2026 Filed Jul 10, 2026 01:17 UTC	Hinge Health, Inc. HNGE · Entity 377	ConversionClass A Common Stock	100,195	Not disclosed	Not disclosed	Disclosure SEC source: 0000899140-26-000710 · form4.xml · nonDerivative · entry 3 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 100,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
July 07, 2026 Filed Jul 10, 2026 01:17 UTC	Hinge Health, Inc. HNGE · Entity 377	ConversionClass A Common Stock	2,907	Not disclosed	Not disclosed	Disclosure SEC source: 0000899140-26-000710 · form4.xml · nonDerivative · entry 2 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 2,907 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
July 07, 2026 Filed Jul 10, 2026 01:17 UTC	Hinge Health, Inc. HNGE · Entity 377	ConversionClass A Common Stock	122,188	Not disclosed	Not disclosed	Disclosure SEC source: 0000899140-26-000710 · form4.xml · nonDerivative · entry 1 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 122,188 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
June 29, 2026 Filed Jun 30, 2026 01:27 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	55	$84.59	$4,652.45	Disclosure SEC source: 0000899140-26-000691 · form4.xml · nonDerivative · entry 24 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 0 F14 · kind: See Exhibit 99.1 F13 · price: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
June 29, 2026 Filed Jun 30, 2026 01:27 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	286	$84.59	$24,192.74	Disclosure SEC source: 0000899140-26-000691 · form4.xml · nonDerivative · entry 23 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 0 F14 · kind: See Exhibit 99.1 F13 · price: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
June 29, 2026 Filed Jun 30, 2026 01:27 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	9	$84.59	$761.31	Disclosure SEC source: 0000899140-26-000691 · form4.xml · nonDerivative · entry 22 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 0 F14 · kind: See Exhibit 99.1 F13 · price: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
June 29, 2026 Filed Jun 30, 2026 01:27 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	349	$84.59	$29,521.91	Disclosure SEC source: 0000899140-26-000691 · form4.xml · nonDerivative · entry 21 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 0 F14 · kind: See Exhibit 99.1 F13 · price: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
June 29, 2026 Filed Jun 30, 2026 01:27 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	44,363	$84.02	$3,727,410.31	Disclosure SEC source: 0000899140-26-000691 · form4.xml · nonDerivative · entry 20 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 55 F14 · kind: See Exhibit 99.1 F12 · price: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
June 29, 2026 Filed Jun 30, 2026 01:27 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	229,334	$84.02	$19,268,803.21	Disclosure SEC source: 0000899140-26-000691 · form4.xml · nonDerivative · entry 19 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 286 F14 · kind: See Exhibit 99.1 F12 · price: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
June 29, 2026 Filed Jun 30, 2026 01:27 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	6,654	$84.02	$559,073.74	Disclosure SEC source: 0000899140-26-000691 · form4.xml · nonDerivative · entry 18 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 9 F14 · kind: See Exhibit 99.1 F12 · price: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
June 29, 2026 Filed Jun 30, 2026 01:27 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	279,671	$84.02	$23,498,153.19	Disclosure SEC source: 0000899140-26-000691 · form4.xml · nonDerivative · entry 17 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 349 F14 · kind: See Exhibit 99.1 F12 · price: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
June 29, 2026 Filed Jun 30, 2026 01:27 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	25,850	$83.18	$2,150,112.53	Disclosure SEC source: 0000899140-26-000691 · form4.xml · nonDerivative · entry 16 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 44,418 F14 · kind: See Exhibit 99.1 F11 · price: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
June 29, 2026 Filed Jun 30, 2026 01:27 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	133,633	$83.18	$11,115,125.22	Disclosure SEC source: 0000899140-26-000691 · form4.xml · nonDerivative · entry 15 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 229,620 F14 · kind: See Exhibit 99.1 F11 · price: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
June 29, 2026 Filed Jun 30, 2026 01:27 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	3,877	$83.18	$322,475.29	Disclosure SEC source: 0000899140-26-000691 · form4.xml · nonDerivative · entry 14 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 6,663 F14 · kind: See Exhibit 99.1 F11 · price: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
June 29, 2026 Filed Jun 30, 2026 01:27 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	162,965	$83.18	$13,554,858.32	Disclosure SEC source: 0000899140-26-000691 · form4.xml · nonDerivative · entry 13 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 280,020 F14 · kind: See Exhibit 99.1 F11 · price: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
June 29, 2026 Filed Jun 30, 2026 01:27 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	11,528	$82.05	$945,848.19	Disclosure SEC source: 0000899140-26-000691 · form4.xml · nonDerivative · entry 12 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 70,268 F14 · kind: See Exhibit 99.1 F10 · price: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
June 29, 2026 Filed Jun 30, 2026 01:27 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	59,592	$82.05	$4,889,398.46	Disclosure SEC source: 0000899140-26-000691 · form4.xml · nonDerivative · entry 11 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 363,253 F14 · kind: See Exhibit 99.1 F10 · price: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
June 29, 2026 Filed Jun 30, 2026 01:27 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	1,729	$82.05	$141,860.82	Disclosure SEC source: 0000899140-26-000691 · form4.xml · nonDerivative · entry 10 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 10,540 F14 · kind: See Exhibit 99.1 F10 · price: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
June 29, 2026 Filed Jun 30, 2026 01:27 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	72,672	$82.05	$5,962,584.99	Disclosure SEC source: 0000899140-26-000691 · form4.xml · nonDerivative · entry 9 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 442,985 F14 · kind: See Exhibit 99.1 F10 · price: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
June 29, 2026 Filed Jun 30, 2026 01:27 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	34,387	$81.31	$2,795,835.04	Disclosure SEC source: 0000899140-26-000691 · form4.xml · nonDerivative · entry 8 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 81,796 F14 · kind: See Exhibit 99.1 F9 · price: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
June 29, 2026 Filed Jun 30, 2026 01:27 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	177,768	$81.31	$14,453,427.24	Disclosure SEC source: 0000899140-26-000691 · form4.xml · nonDerivative · entry 7 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 422,845 F14 · kind: See Exhibit 99.1 F9 · price: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
June 29, 2026 Filed Jun 30, 2026 01:27 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	5,158	$81.31	$419,371.19	Disclosure SEC source: 0000899140-26-000691 · form4.xml · nonDerivative · entry 6 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 12,269 F14 · kind: See Exhibit 99.1 F9 · price: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
June 29, 2026 Filed Jun 30, 2026 01:27 UTC	Hinge Health, Inc. HNGE · Entity 377	SaleClass A Common Stock	216,787	$81.31	$17,625,867.04	Disclosure SEC source: 0000899140-26-000691 · form4.xml · nonDerivative · entry 5 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 515,657 F14 · kind: See Exhibit 99.1 F9 · price: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
June 29, 2026 Filed Jun 30, 2026 01:27 UTC	Hinge Health, Inc. HNGE · Entity 377	ConversionClass A Common Stock	116,183	Not disclosed	Not disclosed	Disclosure SEC source: 0000899140-26-000691 · form4.xml · nonDerivative · entry 4 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 116,183 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document
June 29, 2026 Filed Jun 30, 2026 01:27 UTC	Hinge Health, Inc. HNGE · Entity 377	ConversionClass A Common Stock	600,613	Not disclosed	Not disclosed	Disclosure SEC source: 0000899140-26-000691 · form4.xml · nonDerivative · entry 3 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 600,613 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.